ArticleTherapeutic advances in gastroenterology2025
Identifying inflammatory bowel disease subtypes: a comprehensive exploration of transcriptomic data and machine learning-based approaches.
Article in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Epithelial cell-based multi-omics integration identifies SPINK5 and SRI as novel diagnostic biomarkers for ulcerative colitis.Frontiers in pharmacology · 2026Article
- The Paradox of NET Involvement in the Pathogenesis of Inflammatory Bowel Disease.Inflammatory bowel diseases · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a heterogeneous condition characterised by chronic gastrointestinal inflammation and dysregulated immune responses. Despite advances in transcriptomic analysis and machine learning (ML), consistent molecular subtyping across datasets remains a challenge. There is a critical need for robust subtypes that reflect disease heterogeneity and correlate with clinical outcomes. Objectives: Unlike prior studies focused on either UC or CD or based on small datasets, this study analyses a large-scale RNA sequencing (RNA-seq) dataset to identify transcriptomic subtypes in both UC and CD. Design: We analysed RNA-seq data from four prospective cross-sectional cohorts from Gene Expression Omnibus: GSE193677, GSE186507, GSE137344 and GSE235236. Methods: Analysed RNA-sequenced data from inflamed and non-inflamed intestinal biopsies of 2490 adult IBD patients. Results: Conclusion: We report three transcriptomic subtypes in UC and CD, each with distinct molecular signatures and clinical relevance. These findings support a stratified approach to IBD diagnosis and therapy, enabling more personalised disease management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.